Raj Kamath

Company: Merck & Co

Job title: Executive Director

Seminars:

Unlocking the Potential of Tulisokibart & Harnessing Biomarkers to Elevate Response Rate for Therapeutics in IBD 9:30 am

Sharing insights from the integration of a diagnostic tool in a phase II trial, highlighting successes, challenges, and learnings from its development Discussing the role of patient stratification in advancing therapeutic precision and optimizing treatment pathways for IBD Exploring the future potential of diagnostic innovations in clinical trials and their role in shaping precision medicine…Read more

day: Day One

Panel Discussion: Enhancing Precision Medicine & Optimizing Stratification to Deliver Effective Fibrosis Therapies 9:30 am

Refining stratification approaches to identify high-risk patients for fibrosis Tailoring therapies based on molecular and genetic fibrosis profiles Can biopharma harness stratification tools to improve therapy outcomes and efficiency?Read more

day: Day Two